![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print November 17, 2000
J. Biol. Chem, 10.1074/jbc.M009449200
Submitted on October 17, 2000
Revised on November 17, 2000
Accepted on November 17, 2000
Tumor Biology (H4), Netherlands Cancer Institute, Amsterdam 1066 CX
Corresponding Author: jhi{at}nki.nl
The mucin-like glycoprotein episialin (MUC1) is highly overproduced by a number of human carcinomas. We previously have shown in a variety of mammalian cell lines that overexpression of this very large transmembrane molecule diminishes cellular adhesion, suggesting that episialin/MUC1 overexpression may play an important role in tumor invasion and metastasis. Using in situ hybridization, we show here that episialin/MUC1 mRNA expression can be increased more than 10 fold in breast carcinoma cells relative to the expression in adjacent normal breast epithelium. In search of the molecular mechanism of this overexpression, we observed that the episialin/MUC1 promoter contains a candidate binding site for transcription factors of the STAT-family (STAT = Signal Transducer and Activator of Transcription) approximately 500 bp upstream of the transcription start site. Cytokines and/or growth factors such as interleukin-6 (IL-6) or interferon gamma (IFN-
) can activate STATs. In the human breast carcinoma cell line T47D, both compounds are able to stimulate transcription of a luciferase reporter gene under the control of a 750 bp MUC1 promoter fragment proximal to the transcription start site. The observed increase is entirely mediated by the single STAT-binding site, since mutation of this site abolishes stimulation of the reporter by IL-6 and IFN-
. In addition, mutation of the STAT site also decreased the promoter activity in non-stimulated T47D cells, suggesting that the STAT binding site is among the elements that are involved in the overexpression of MUC1 in tumor cells.
This article has been cited by other articles:
![]() |
S. Wilkie, G. Picco, J. Foster, D. M. Davies, S. Julien, L. Cooper, S. Arif, S. J. Mather, J. Taylor-Papadimitriou, J. M. Burchell, et al. Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor J. Immunol., April 1, 2008; 180(7): 4901 - 4909. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kuwahara, E. P. Lillehoj, T. Koga, Y. Isohama, T. Miyata, and K. C. Kim The Signaling Pathway Involved in Neutrophil Elastase Stimulated MUC1 Transcription Am. J. Respir. Cell Mol. Biol., December 1, 2007; 37(6): 691 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Brayman, N. Dharmaraj, E. Lagow, and D. D. Carson MUC1 Expression Is Repressed by Protein Inhibitor of Activated Signal Transducer and Activator of Transcription-y Mol. Endocrinol., November 1, 2007; 21(11): 2725 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koga, I. Kuwahara, E. P. Lillehoj, W. Lu, T. Miyata, Y. Isohama, and K. C. Kim TNF-{alpha} induces MUC1 gene transcription in lung epithelial cells: its signaling pathway and biological implication Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L693 - L701. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Beatty, S. E. Plevy, A. R. Sepulveda, and O. J. Finn Cutting Edge: Transgenic Expression of Human MUC1 in IL-10-/- Mice Accelerates Inflammatory Bowel Disease and Progression to Colon Cancer J. Immunol., July 15, 2007; 179(2): 735 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Siragusa, M. Zerilli, F. Iovino, M. G. Francipane, Y. Lombardo, L. Ricci-Vitiani, G. Di Gesu, M. Todaro, R. De Maria, and G. Stassi MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells Cancer Res., June 1, 2007; 67(11): 5522 - 5530. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kondo, T. Yoshizaki, N. Wakisaka, T. Horikawa, S. Murono, K. L. Jang, I. Joab, M. Furukawa, and J. S. Pagano MUC1 Induced by Epstein-Barr Virus Latent Membrane Protein 1 Causes Dissociation of the Cell-Matrix Interaction and Cellular Invasiveness via STAT Signaling J. Virol., February 15, 2007; 81(4): 1554 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Brayman, J. Julian, B. Mulac-Jericevic, O. M. Conneely, D. P. Edwards, and D. D. Carson Progesterone Receptor Isoforms A and B Differentially Regulate MUC1 Expression in Uterine Epithelial Cells Mol. Endocrinol., October 1, 2006; 20(10): 2278 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kuwahara, E. P. Lillehoj, A. Hisatsune, W. Lu, Y. Isohama, T. Miyata, and K. C. Kim Neutrophil elastase stimulates MUC1 gene expression through increased Sp1 binding to the MUC1 promoter Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L355 - L362. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Cramer, L. Titus-Ernstoff, J. R. McKolanis, W. R. Welch, A. F. Vitonis, R. S. Berkowitz, and O. J. Finn Conditions Associated with Antibodies Against the Tumor-Associated Antigen MUC1 and Their Relationship to Risk for Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1125 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-l. Yuan, Y.-j. Guan, L. Wang, W. Wei, A. B. Kane, and Y. E. Chin Central Role of the Threonine Residue within the p+1 Loop of Receptor Tyrosine Kinase in STAT3 Constitutive Phosphorylation in Metastatic Cancer Cells Mol. Cell. Biol., November 1, 2004; 24(21): 9390 - 9400. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin, Y. Li, J. Ren, H. Kuwahara, and D. Kufe Human MUC1 Carcinoma Antigen Regulates Intracellular Oxidant Levels and the Apoptotic Response to Oxidative Stress J. Biol. Chem., September 12, 2003; 278(37): 35458 - 35464. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Z. Rassidakis, A. Goy, L. J. Medeiros, Y. Jiang, A. Thomaides, Y. Remache, F. Cabanillas, A. H. Sarris, and F. Gilles Prognostic Significance of MUC-1 Expression in Systemic Anaplastic Large Cell Lymphoma Clin. Cancer Res., June 1, 2003; 9(6): 2213 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hinojosa-Kurtzberg, M. E. V. Johansson, C. S. Madsen, G. C. Hansson, and S. J. Gendler Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G853 - G862. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Lee, S. W. Hyun, A. Nandi, and K. C. Kim Transcriptional regulation of the hamster Muc1 gene: identification of a putative negative regulatory element Am J Physiol Lung Cell Mol Physiol, January 1, 2003; 284(1): L160 - L168. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |